Skip to content

Mini-Mental State (MMS-LS) and Sign Language

Transposition of the Mini-Mental State in Sign Language

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005679
Acronym
MMS-LS
Enrollment
195
Registered
2013-12-09
Start date
2011-06-17
Completion date
2017-12-07
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prelingual Deafness, Retention Disorders, Cognitive

Keywords

Prelingual Deafness, Retention Disorders, Cognitive, Sign language, Mini-Mental State

Brief summary

In France the prevalence of pre-lingual deafness is between 1 and 1.4 per 1000 habitants, and according to very conservative estimates, about 44 000 deaf persons use the sign language. Additionally, the prevalence of dementia in France is close to 1% (850 000 dements for a total population of 65 millions). The prevalence of dementia in pre-lingual deaf adults has also been described and is between 1 and 1.4 /100 000 habitants. The Mini Mental State Examination (MMSE) of Folstein is a test recommended to perform the cognitive evaluation for the detection of mental disorders including dementia, and a consensual French version exists prepared by GRECO (Group of Research and Cognitive Assessments). However, to date, there are no simple, rapid and validated screening tests to study cognitive disorders in deaf persons who use the sign language. The only tests available allow a late diagnosis avoiding an optimal treatment of the patients.

Detailed description

The objective of this study is to assess the intrinsic quality of the tool MMS-LS, a mini-mental state examination that has been adapted to the sign language in order to monitor cognitive disorders in deaf people who speak sign language.

Interventions

BEHAVIORALapplication of the mini-mental state test

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults\> 18 years * Pre-lingual deafness * Use of French sign language

Exclusion criteria

* Refusal to sign the consent * Severe visual impairment with lower acuity (less than 0.5) * Severe motor difficulties impeding the practice of sign language

Design outcomes

Primary

MeasureTime frame
Assessment of internal consistency of MMS-LS test for the diagnosis of cognitive impairment among deaf patients by a correlation analysis followed by Cronbach's alpha testAt baseline, 1 year and 2 years follow-up visits

Secondary

MeasureTime frameDescription
Description of MMS-LS test resultsBaselineExplanatory Factors are: age, education level, characteristics of the sign language(fluency level, learning age, usage frequency, usage by other family members)
Diagnostic performance and predictive values of MMS-LS test for acquired dementia.Baseline, 1 year and 2 years follow-up visitsSensitivity, specificity, positive and negative predictive values.
Correlation between MMS-LS score and CDR levelBaseline, 1 year and 2 years follow-up visitsWe also check that patients having a suspicious CDR (0.5) have a superior MMS-LS score compared to patients having a CDR ≥ 1.
Diagnostic performance and predictive values of MMS-LS test for suspected dementia.Baseline, 1 year and 2 years follow-up visitsSensitivity, specificity, positive and negative predictive values

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026